Icon Close

Seagen is now part of Pfizer!  Please visit Pfizer.com for more information.

For US residents only.

Seagen is now part of Pfizer! This page will no longer be updated, but you can visit Pfizer.com for more information on this change, or visit the "Research & Business Development Partnerships" page on Pfizer.com
Who We Are

Partnerships

quotes

To advance innovation and our mission to help oncology patients, we collaborate with other industry-leading biotechnology, pharmaceutical, and emerging biotech companies.

Natasha Hernday

Chief Business Officer

In it for life, together

Our partnerships focus on:

  • Innovative in-licensing opportunities at all development stages to diversify and grow our emerging global portfolio
  • Clinical and research collaborations that broaden the potential of our internal programs
  • Novel platform technologies that synergize with or expand our antibody–drug conjugate (ADC) capabilities in new and unique ways

Connect with us

To explore partnership opportunities, please contact businessdevelopment@seagen.com.

OUR TEAM

seagen corporate development team

Steven Bartz

Vice President, Corporate Development

seagen corporate development team

Wesley Galamb

Sr. Director, Corporate Development

seagen corporate development team

Kelly Callahan

Sr. Manager, Corporate Development

OUR CO-DEVELOPMENT AND COMMERCIAL PARTNERS

Seagen collaborator Astellas
Seagen collaborator Genmab
Seagen collaborator Merck
Seagen collaborator Takeda
Seagen collaborator RemeGen

OUR CLINICAL COLLABORATORS

Seagen collaborator Bristol Myers Squibb
Seagen collaborator Genentech
Seagen collaborator Merck

OUR ADC TECHNOLOGY COLLABORATORS

Seagen collaborator Abbvie
Seagen collaborator Genentech
Seagen collaborator GlaxoSmithKline